The Case to Realign Parkinson ’s Disease Research
Conclusion
PD research is spread out in many directions, but after 50 years of trying, it is still decades away from finding a cure. That realization must sink in to its participants before a change in approach is accepted.
The requisite changes are: 1) a focus on multivariate solutions; 2) an overlay industry structure that coordinates the focus and funding of PD research and tracks performance and 3) a modified approach to FDA regulation. Once these changes are put in place, the funding of PD research should be increased substantially over the next several years with the singular objective of finding a cure.
Steven Zecola is the managing director of Competitive Strategies and has held executive positions in large companies and the federal government.
Source: The Health Care Blog - Category: Consumer Health News Authors: Christina Liu Tags: Medical Practice Patients Parkinson's Disease Steven Zecola Source Type: blogs
More News: Biochemistry | Blogging | Brain | Carbidopa/Levodopa | Clinical Trials | Conferences | Environmental Health | Genetics | Grants | Health | Health Management | Lessons | Neurology | Neuroscience | Parkinson's Disease | Pharmaceuticals | Poland Health | Science | Sleep Disorders | Sleep Medicine | Stem Cell Therapy | Stem Cells | Stroke | Study | USA Health | Websites